0001104659-21-066263.txt : 20210514 0001104659-21-066263.hdr.sgml : 20210514 20210514061007 ACCESSION NUMBER: 0001104659-21-066263 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210514 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Data Inc. CENTRAL INDEX KEY: 0001758736 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39167 FILM NUMBER: 21921818 BUSINESS ADDRESS: STREET 1: 5/F,BUILDING 12,1001 NORTH QINZHOU ROAD STREET 2: XUHUI DISTRICT CITY: SHANGHAI STATE: F4 ZIP: 201109 BUSINESS PHONE: 862154365166 MAIL ADDRESS: STREET 1: 5/F,BUILDING 12,1001 NORTH QINZHOU ROAD STREET 2: XUHUI DISTRICT CITY: SHANGHAI STATE: F4 ZIP: 201109 6-K 1 tm2116435d1_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2021

 

 

 

Commission File Number: 001- 39167

 

 

 

Molecular Data Inc.

 

11/F, Building 15, 2177 Shenkun Road

Minhang District, Shanghai 201106

People’s Republic of China
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F     x              Form 40-F      ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1*   Molecular Data announces that it entered into an agreement with Oasis Capital, LLC to sell up to $50 million of ADRs to Oasis  from time to time.

 

 

 

  * Exhibit 99.1 is furnished herewith solely for the purpose of meeting the requirements under Nasdaq Stock Market Rule 5250(c)(2) in connection with submission of an interim balance sheet and income statement as of the end of its second quarter.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Molecular Data Inc.
       
       
  By  : /s/ Steven Foo
  Name : Steven Foo
  Title : Chief Financial Officer

 

Date: 14 May, 2021

 

 

 EX-99.1 2 tm2116435d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

  Molecular Data announces that it entered into an agreement with Oasis Capital, LLC to sell up to $50 million of ADRs to Oasis  from time to time.